Press Releases

Theracell And AlloSource Announce Second Patent For Bone Fiber Technology

Demineralized Bone Fiber (DBF™) patent to expand TheraCell’s osteobiologic patent portfolio Northridge, Cali. and Centennial, Colo. — March 9, 2017 — TheraCell, a regenerative medicine company, today announced it was awarded a second patent for its demineralized bone fiber (DBF™) technology by the United States Patent and Trademark Office. The addition of U.S. Patent Number 9,572,912, titled Demineralized bone fibers having controlled geometry and shapes and methods thereof, expands TheraCell’s intellectual property portfolio, demonstrating its ongoing commitment to innovation and leadership in the orthopedic allograft industry. TheraCell’s DBF™ technology is incorporated into two innovative demineralized cortical fiber allografts, AlloFuse® Cortical…

AlloSource Announces The Annual Dr. Steven Gitelis Inspiration Award

Company honors Dr. Brian Cole with the inaugural award Centennial, Colo. — January 24, 2017 — AlloSource, one of the nation’s largest providers of cartilage, cellular, bone, skin and soft-tissue allografts for use in surgical procedures and wound care to advance patient healing, announced the creation of the Dr. Steven Gitelis Inspiration Award. The award honors a doctor or clinician that inspires AlloSource through his or her work in treating patients with donated human allografts. Dr. Brian Cole of Midwest Orthopaedics at Rush University Medical Center is the inaugural 2017 recipient. The award’s namesake, Dr. Steven Gitelis, is one of…

AlloSource Business Process Manager Designated Malcolm Baldrige National Quality Award Examiner, Deepening Company’s Commitment To Performance Excellence

Centennial, Colo. — December 6, 2016 — AlloSource, one of the nation’s largest providers of cartilage, cellular, bone, skin and soft-tissue allografts for use in surgical procedures, recognized Kimberly Meyer, Business Process Manager, for being named to the Board of Examiners for the 2016 Malcolm Baldrige National Quality Award by the Commerce Department’s National Institute of Standards and Technology (NIST), deepening the organization’s commitment to process excellence. The Baldrige Award is the nation’s highest honor for organizational innovation and performance excellence. Appointed by the NIST Director, examiners are responsible for reviewing and evaluating applications submitted for the Baldrige Award, as…

TheraCell And AlloSource Announce Issuance Of Patent For Bone Fiber Technology

Northridge, Calif. and Centennial, Colo. — Oct. 25, 2016 — TheraCell, a regenerative medicine company, today announced that the United States Patent and Trademark Office (USPTO) will issue TheraCell a patent for its demineralized bone fiber (DBF™) technology. The addition of this patent expands TheraCell’s patent portfolio, demonstrating its ongoing commitment to innovation and leadership in the orthopedic allograft industry. TheraCell’s DBF technology is incorporated into two new innovative demineralized cortical fiber allografts, AlloFuse® Cortical Fibers and AlloFuse® Fiber Boats, provided by AlloSource®, one of the nation’s largest providers of cartilage, cellular, bone, skin and soft-tissue allografts. AlloFuse Cortical Fibers…

AlloSource Receives Phoenix Society For Burn Survivors’ Harman Award

Centennial, Colo. — October 21, 2016 — AlloSource, one of the nation’s largest providers of cartilage, cellular, bone, skin and soft-tissue allografts to advance patient healing, received the Phoenix Society for Burn Survivors’ Harman Award for philanthropic leadership. The award is presented to an individual, family, corporation, foundation or service organization with a proven record of exceptional generosity through direct financial support and charitable responsibility. In 2013, AlloSource pledged an annual financial contribution to fund the Phoenix Society’s Educational Grant Program – the first and only national scholarship program created for burn survivor students. Over 163 students have received an…

International Cartilage Repair Society Symposia To Highlight Early Findings Of ProChondrix Cartilage Restoration Matrix

Centennial, Colo. — September 23, 2016 — AlloSource, one of the nation’s largest providers of cartilage, cellular, bone, skin and soft-tissue allografts for use in surgical procedures and wound care to advance patient healing, will share early results of its fresh cartilage allograft, ProChondrix® Cartilage Restoration Matrix during the International Cartilage Repair Society’s (ICRS) 13th World Congress in Sorrento-Naples, Italy. The Industry Satellite Lunch Symposia will take place on Monday, 26 September 2016 from 13:00 to 13:30 in the Sala Nettuna Room. Vishal Mehta, M.D., orthopedic surgeon from Fox Valley Orthopedics in Geneva, Illinois, will present early results of ProChondrix…

AlloSource Supports NASA And Jet Propulsion Laboratory On Microbial Study

Centennial, CO — August 25, 2016 — AlloSource, one of the nation’s largest providers of skin, bone and soft tissue allografts for use in surgical procedures and the world’s largest processor of cellular bone allografts, worked with NASA and the Jet Propulsion Laboratory (JPL) on microbial research that could help improve medical care for astronauts in space. AlloSource collaborated with NASA and JPL scientists on a study to characterize the effects of zero gravity on antibiotic resistant genes in microorganisms taken from the International Space Station (ISS). In this role, AlloSource assisted in describing antimicrobial capabilities of microbes isolated from…

AlloSource Receives Orthopedics This Week Sports Medicine Award For ProChondrix Cartilage Restoration Matrix

Centennial, Colo. — July 7, 2016 — AlloSource, one of the nation’s largest providers of cartilage, cellular, bone, skin and soft-tissue allografts for use in surgical procedures and wound care to advance patient healing, today announced that it received Orthopedics This Week’s first annual Sports Medicine Award for its fresh cartilage allograft, ProChondrix®. The First Annual Sports Medicine Award recognizes engineering excellence, innovation and advancement of sports medicine. Orthopedics This Week presented awards in three technology categories: Diagnostic/Monitoring/Fitness Measurement, Rehabilitation, and Surgical Implants and Instruments. ProChondrix received an award in the Surgical Implant and Instrument category. “ProChondrix was inspired by…

Preclinical Study Validates Science Behind AlloSource’s AlloStem Cellular Bone AlloGraft

Centennial, Colo. — July 6, 2016 — AlloSource, one of the nation’s largest providers of cartilage, cellular, bone, skin and soft-tissue allografts for use in surgical procedures and wound care to advance patient healing, today announced that Dr. Nicole Ehrhart, Professor of Surgical Oncology at the Colorado State University (CSU) Flint Animal Cancer Center, presented preclinical data on adiposederived mesenchymal stem cells at the State of Spine Surgery 13th Annual Symposium and will present at the Korean American Spine Society meeting on July 9, 2016. Dr. Ehrhart’s preclinical study, entitled Adipose-Derived Mesenchymal Stromal Cells Seeded on Demineralized Bone Matrix Persist…

AlloSource Announces Two Innovative Bone Fiber AlloGrafts

AlloFuse® Cortical Fibers and AlloFuse® Fiber Boat will expand the company’s osteobiologic bone graft portfolio Centennial, Colo. — June 13, 2016 — AlloSource, one of the nation’s largest providers of cartilage, cellular, bone, skin and soft-tissue allografts for use in surgical procedures and wound care to advance patient healing, today announced the launch of two new innovative demineralized cortical fiber allografts, AlloFuse® Cortical Fibers and the AlloFuse® Fiber Boat, for use in a variety of spine and orthopedic procedures. TheraCell, a regenerative medicine company, developed and patented the demineralized bone fiber (DBF™) technology used in these products and partnered with…